564 Results (Page 23 of 23)
Japan Markets Research Reports
Japan Cancer Induced Bone Diseases Therapeutics Market
Japan Cancer Induced Bone Disease Therapeutics Market valued at $81 Mn in 2022, projected to reach $132 Mn by 2030 with a 6.3% CAGR. The key drivers of this industry include the increasing cancer incidence, technological advancements, and unmet medical needs. The industry is primarily dominated by players such as Daiichi Sankyo, Bayer, Merck, Chugai, Takeda, Novartis, Amgen, and Eisai among others.
Japan Congestive Heart Failure Therapeutics Market Analysis
The Japan Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $640 Mn in 2022 to $1,044 Mn by 2030, with a CAGR of 6.3% during the forecast period of 2022-2030. The primary driving factors include the growing emphasis on quality of life, technological developments in medicine that provide novel therapeutic approaches, and the rising incidence of heart failure as a result of aging populations and sedentary lifestyles in Japan. The Japan Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including Novartis, AstraZeneca, Bayer, Merck, Pfizer, Boehringer Ingelheim, Otsuka, Sumitomo Pharma, Eisai, Meiji Seika Pharma, etc, among various others.
Japan Digital Biomarkers Market Analysis
Japan Digital Biomarkers Market was valued at $180.26 Mn in 2023 and is predicted to grow at a CAGR of 22.8% from 2023 to 2030, to $759.08 Mn by 2030. The key drivers of this industry include the growing prevalence of chronic diseases, the aging population, and the focus on innovation. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Japan Medication Access Programs Market Analysis
The Japan Medication Access Programs Market was valued at $341.2 Mn in 2023 and is predicted to grow at a CAGR of 15.1% from 2023 to 2030, to $913.2 Mn by 2030. The key drivers of this industry include an aging population, government support, and a high prevalence of diseases. The industry is primarily dominated by players such as Gilead Sciences, Takeda Pharmaceuticals, Pfizer, Novartis, and Merck among others.
Japan Cardiac Resynchronization Therapy Market
Japan Cardiac Resynchronization Therapy Market valued at $298 Mn in 2022, projected to reach $458 Mn by 2030 with a 5.5% CAGR. The global surge in heart failure cases, driven by aging populations and lifestyle-related cardiovascular diseases, is a significant catalyst contributing to the expansion of the Cardiac Resynchronization Therapy (CRT) market. Currently, major contributors to this market include companies such as Abbott, Biotronik, Boston Scientific, Medtronic, Nihon Kohden, Oscor, Siemens Healthineers, Sorin Group, MicroPort CRM, and Osram Health.
Japan Biosensors Market Analysis
The Japan Biosensors Market was valued at $1796.4 Mn in 2023 and is predicted to grow at a CAGR of 8.5% from 2023 to 2030, to $3179.9 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, increasing demand for accurate disease diagnosis, and growing demand for Point-of-Care (POC) testing. The prominent players of the Japan Biosensors Market are Nipro, Terumo Corporation, Abbott Laboratories, Medtronic, Bio-Rad International, Siemens Healthcare, and F. Hoffmann- La Roche, among others.
Japan Physiotherapy Equipment Market Analysis
The Japan Physiotherapy Equipment Market was valued at $1,299.12 Mn in 2023 and is predicted to grow at a CAGR of 7.7% from 2023 to 2030, to $2,183.52 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are Takeda Medical, Fujirebio, Nihon Kohden, and Enraf-Nonius BV among others.
Japan Dental Consumables Market Analysis
The Japan Dental Consumables Market was valued at $2101 Mn in 2023 and is projected to grow at a CAGR of 8.5% from 2023 to 2023, to $3719 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to rising urbanization, changing living standards. The industry is primarily dominated by players such as GC Corporation, Shofu Inc, Kuraray Noritake Dental Inc, Dentsply Sirona, 3M, Sun Medical Co Ltd among others.
Japan Patient Adherence Programs Market Analysis
The Japan Patient Adherence Programs Market was valued at $805.3 Mn in 2023 and is predicted to grow at a CAGR of 18.5% from 2023 to 2030, to $2642.4 Mn by 2030. The key drivers of the market include rising non-adherence, technological innovations, and healthcare cost containment. The prominent players of the Japan Patient Adherence Programs Market are Takeda Pharmaceutical Company, Astellas Pharma, Daiichi Sankyo, Eisai Co., Ltd., and Otsuka Pharmaceuticals, among others.
Japan Cardiac Arrhythmia Therapeutics Market
Japan Cardiac Arrhythmia Therapeutics Market valued at $448 Mn in 2022, projected to reach $730 Mn by 2030 with a 6.3% CAGR. The key drivers of this industry include the rising prevalence of cardiac arrhythmias, supportive government initiatives, and technological advancements. The industry is primarily dominated by players such as Abbott, Philips Healthcare, Boston Scientific, Olympus, Terumo, and Esaote among others.
Japan LASIK Surgery Market Analysis
Japan LASIK Surgery Market was valued at $219.42 Mn in 2023 and is predicted to grow at a CAGR of 5.71% from 2023 to 2030, to $323.66 Mn by 2030. The key drivers of this industry include aging population and presbyopia, technological advancements, and established ophthalmology market. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
Japan Medical Digital Imaging System Market Analysis
The Japan Medical Digital Imaging System Market was valued at $1895.84 Mn in 2023 and is predicted to grow at a CAGR of 8.70% from 2023 to 2030, to $3399.45 Mn by 2030. The key drivers of this industry include an aging population, healthcare infrastructure, and technological advancements. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.
Japan Hemodialysis Vascular Grafts Market Analysis
Japan Hemodialysis Vascular Grafts Market was valued at $13.02 Bn in 2023 and is predicted to grow at a CAGR of 5.6% from 2023 to 2030, to $19.06 Bn by 2030. The key drivers of this industry include an aging population, a high prevalence of ESRD, and government support for healthcare. The industry is primarily dominated by W. L. Gore, C. R. Bard, Vascudyne, and LeMaitre among others.
Japan Breastfeeding Accessories Market Analysis
Japan Breastfeeding Accessories Market was valued at $156.02 Mn in 2023 and is predicted to grow at a CAGR of 7.30% from 2023 to 2030, to $255.49 Mn by 2030. The key drivers of this industry include increasing breastfeeding rates, government initiatives and support, and technological advancements in breastfeeding products. The industry is primarily dominated by Medala, Elvie, Willow Innovations, and Koninklijke Philips among others.
